All Type of News
Celltrion’s personnel reshuffle in C-level
Celltrion Group will perform a personnel reshuffle to establish a base to expand and accelerate its global biopharmaceutical business.
According to Celltrion Group, Celltrion promoted CO-CEO Woo-Sung Ki and Hyung-Gi ...
‘Artificial Intelligence’ over hypothesis-driven study
An opinion was raised that development of new drugs must go towards AI, not the conventional hypothesis-driven studies.
At the ‘Artificial Intelligence, New Paradigm of New Drug Development’ seminar on the 7th, Profe...
Government invested KRW 3 trillion into R&D in health & medical field
The pharmaceutical industry has reportedly invested KRW 3 trillion for the last 3 years, which was the period of the ‘1st Health and Medical Technology Promoting Plan’ from the year of 2013.
The Korea Health Industry...
MOHW to proceed 10th meeting with medical field as scheduled late March
Assuming they would like to continue having a sincerely conversation with the medical field about the National Health Insurance Coverage Extension Plan(Moon Jae-In Care), the Ministry of Health and Welfare announced t...
Pharma field’s heart ‘pounding’ over whether prosecution would put a hand on CSOs for illegal rebates
While pharmaceutical companies have had sharp attention to whether the prosecution would put a hand on CSOs(contract sales organizations), which has been suspicious of being a window for illegal rebates, it is anticip...
Pharmaceutical industry has high potentials for Korea-India cooperation
The pharmaceutical industry has been chosen as a potential industry for Korean small & medium companies to cooperate between Korea and India. An analysis result showed it a rare case where Korea and India might genera...
‘Edarbi’ co-marketed by Takeda Pharmaceuticals & Dong-A ST enters Seoul National University Hospital
‘Edarbi’ jointly sold by Takeda Pharmaceuticals and Dong-A ST has entered Seoul National University Hospital.
At the Drug Committee on the last 2nd, Seoul National University let various drugs, like ‘Edarbi.’ LG Chem...
11 Korean-developed medicines break the U.S. and EU wall of approval
11 medicines which were developed by Korean pharmaceutical companies after 2013 have reportedly been well sold as breaking the wall of approval of the U.S. and European Union.
According to the Ministry of Health and ...
“It’s about to announce the 2018 plans for the 2nd pharmaceutical general plans”
The Ministry of Health and Welfare said they would announce the 2018 enforcement plans for the 2nd pharmaceutical general plans. They promised valuation of new drugs and tax support for innovative growth of pharmaceut...
Korean pharmas getting closer to U.S. market, changing market trend within 4 to 5 years
Pharmaceutical companies dreaming to become a global pharmaceutical company are focusing on creating new drug pipelines. This is because it seems they might be decided to become one by how successful their new drug pi...
